DAVIS JOHN C. JR

CIK 00017412871 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001741287

Recent Transactions

20 trades

Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2021-02-11+72,500→ 72,500 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2020-04-14+50,000→ 50,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2020-02-10+104,000→ 104,000 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2020-01-02−11,294→ 224,831 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2020-01-02$15.04/sh−11,294→ 8,304 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2020-01-02$9.49/sh+11,294→ 19,598 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2019-12-20−805→ 236,239 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-20$15.00/sh−919→ 8,304 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2019-12-20−114→ 236,125 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-20$9.49/sh+114→ 8,418 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-20$9.49/sh+805→ 9,223 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-10$9.49/sh+17,055→ 25,359 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2019-12-10−17,055→ 237,044 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-10$15.00/sh−17,055→ 8,304 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-09$9.49/sh+4,614→ 12,918 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2019-12-09−4,614→ 254,099 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-09$15.00/sh−4,614→ 8,304 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2019-02-05+70,000→ 70,000 total
Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2018-06-25+8,304→ 8,304 total
Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Series C Preferred Stock
2018-06-25−21,459→ 0 total

Companies

Dianthus Therapeutics, Inc. /DE/
Chief Medical Officer
$DNTH

Recent Filings

Address

C/O MAGENTA THERAPEUTICS, INC. 50 HAMPSHIRE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov